Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer

OBJECTIVE: The purpose of this study is to review CDK 4/6 inhibitors used to treat metastatic breast cancer for patient safety, cost and utilization. By evaluating patient outcomes and payer influence, this study will provide critical information to aid prescribers in therapeutic decisions. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Husinka, Lakyn, Koerner, Pamela H., Miller, Rick T., Trombatt, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751387/
https://www.ncbi.nlm.nih.gov/pubmed/33414982
http://dx.doi.org/10.1080/21556660.2020.1857103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751387/
https://www.ncbi.nlm.nih.gov/pubmed/33414982
http://dx.doi.org/10.1080/21556660.2020.1857103

Ejemplares similares